亚宝药业（广东横琴）有限公司成立，注册资本1亿

Group 1 - A new company, Yabao Pharmaceutical (Guangdong Hengqin) Co., Ltd., was established on December 24, with a registered capital of 100 million RMB [1] - The legal representative of the new company is Ren Wuxian, indicating a structured leadership [1] - The business scope includes medical research and experimental development, biochemistry product technology research and development, and bio-based material polymer technology research and development [1] Group 2 - The shareholders of the new company are Yabao Pharmaceutical and Yabao Pharmaceutical (Macau) Co., Ltd., reflecting a strategic partnership [1]